Fast – Lean – Strategic


The healthcare industry is extremely complex

due to

  • regulatory issues
  • direct-to-patient marketing and
  • the powerful bond of privacy and trust between providers and patients.
Whether addressing physician or patient, we comprehend the fast changing issues involved in bettering the lives of patients.
 
The upside to better patient care is unlimited.

You know – we know

AMG, AMNOG, ATC, Benefit Assessment of Pharmaceuticals, BfArM, Biologics, Biosimilars, BLA, BMG, Breakthrough Therapy Designation, CHMP, CME, Compassionate Use, Compliance, DocCheck, EC, EMA, EPAR, FDA, G-BA, Generic, HCP, HWG, ICD-10, INN, IQWiG, Labelling, Lay Audience, Leaflet, MAA, MHRA, NCI, NDA, NICE, NIH, NPP (§ 73,3 AMG), NUB, OD, Off-Label-Use, Orphan Drugs, OL, OTC, PBM, PDUFA, PEI, Pharmacovigilance, Positive Opinion, Priority Review Designation, RA, Recombinant, Reference Prices, SGB V, Small Molecule …

Our Clients:

AMGEN


GHD
GILEAD
IQVIA
MSD

BeiGene: Rollout of European web presences

Powering Lung Cancer Awareness Month

One of our numerous Medinota-Consent Projects in collaboration with IQVIA

BioNTech

From now on AMGEN´s German HCP site uses Artificial intelligence for its digital assistant

AMGEN

Hematology & Oncology News

Osteoporosis

Treatment of Hemophilia

Multiple-Sklerose.com recently launched

Gilead Sciences: Campus Infektiologie 2021

AMGEN Corporate Website Germany:

Joachim Freischem & Georg Puluj - Prinzenstr. 12 - D-80639 München (Nymphenburg)
Phone: +49/89/2020 9080 - VAT-No.: DE169293019 - info@aeses.de - Datenschutzerklärung